Breast Biopsy Market
Breast Biopsy Market is segmented by Product (Vacuum-Assisted Device (VAD), Guide Wire (Localization Wire), Breast Biopsy Marker, Biopsy Needle, MRI-Guide Biopsy Systems, Ultrasound Guided Breast Biopsy Systems), Indication (Suspicious solid mass (fibroadenoma), Complex cyst, Solid mass, Suspicious micro-calcifications), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Cancer Research Institutes), and Region. Forecast for 2026 to 2036.
Historical Data Covered: 2016 to 2024 | Base Year: 2025 | Estimated Year: 2026 | Forecast Period: 2027 to 2036
Breast Biopsy Market Size, Market Forecast and Outlook By FMI
The breast biopsy market was valued at USD 2.5 billion in 2025. The market is set to reach USD 2.6 billion by 2026-end and grow at a CAGR of 5.3% between 2026-2036 to reach USD 4.4 billion by 2036. Vacuum-Assisted Device (VAD) will dominate with a 28.9% share, while Suspicious solid mass (fibroadenoma) will lead with a 32.2%% share.
Summary of the Breast Biopsy Market
- Demand and Growth Drivers
- Demand growth reflects expanding application scope and increasing adoption across core end-use segments during the forecast period.
- Cost optimization pressures are expected to drive procurement toward established suppliers with proven performance and competitive pricing.
- Regional infrastructure development is likely to support incremental demand across emerging markets with expanding industrial capacity.
- Product and Segment View
- Vacuum-Assisted Device (VAD) is likely to remain the leading product segment at 28.9%, supported by sustained demand from core end-use applications and favorable procurement conditions.
- Suspicious solid mass (fibroadenoma) is likely to lead the indication segment at 32.2%, driven by sustained demand from core end-use applications and favorable procurement conditions.
- Hospitals is expected to account for 26.9% of the end user segment, reflecting sustained demand from core end-use applications and favorable procurement conditions.
- Geography and Competitive Outlook
- China is likely to remain a key market at 7.2% CAGR, supported by expanding production capacity and increasing demand from core end-use sectors.
- India is expected to sustain demand at 6.6% CAGR, driven by regulatory compliance requirements and infrastructure investment.
- Companies that combine manufacturing scale, product breadth, and established distribution access are likely to strengthen their competitive position during the forecast period.
- Analyst Opinion
- Sabyasachi Ghosh, Principal Consultant at FMI says, 'The breast biopsy market is evolving as demand patterns shift across established and emerging application categories. Companies that can deliver consistent quality at competitive pricing while expanding geographic reach are likely to gain traction during the forecast period. Growth in China reflects expanding industrial and commercial demand.'
- The breast biopsy market is transitioning from early adoption into a more defined procurement category with established supplier qualification criteria.
- Adoption is being shaped by evolving regulatory requirements and shifting buyer preferences toward proven, cost-effective solutions.
- Demand is further supported by infrastructure expansion in high-growth economies and increasing quality standards across established markets.
Breast Biopsy Market Definition
The breast biopsy market encompasses products and solutions categorized by product, indication, end user. The market covers commercially traded breast biopsy products supplied through established distribution channels for industrial, commercial, and institutional end users across global markets.
Breast Biopsy Market Inclusions
Market scope encompasses all commercially traded breast biopsy products categorized by product (Vacuum-Assisted Device (VAD), Guide Wire (Localization Wire), Breast Biopsy Marker, Biopsy Needle, MRI-Guide Biopsy Systems, Ultrasound Guided Breast Biopsy Systems); indication (Suspicious solid mass (fibroadenoma), Complex cyst, Solid mass, Suspicious micro-calcifications); end user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Cancer Research Institutes). The range of revenue sizes is from 2026 to 2036.
Breast Biopsy Market Exclusions
The scope does not include products or services not directly classified within the defined breast biopsy product categories, custom prototypes, or non-commercial research-grade materials.
Breast Biopsy Market Research Methodology
- Primary Research: FMI analysts conducted interviews with manufacturers, distributors, and end-use industry participants across key markets.
- Desk Research: Combined data from industry associations, regulatory filings, trade publications, and manufacturer disclosures.
- Market Sizing and Forecasting: Bottom-up aggregation across product segments, applications, and regional adoption curves with top-down validation.
- Data Validation: Cross-checked quarterly against industry production data and manufacturer information.
Why is the Breast Biopsy Market Growing?
- Tightening quality standards and expanding production capacity across regulated industries are creating sustained demand for breast biopsy products in both established and emerging markets.
- China leads growth at 7.2% CAGR, supported by infrastructure investment, manufacturing modernization, and increasing compliance requirements.
The breast biopsy market is expanding as quality control requirements and production standards tighten across regulated industries. Vacuum-Assisted Device (VAD) accounts for 28.9% of the product segment, driven by sustained demand from core end-use applications and favorable procurement conditions. Procurement patterns reflect a preference for established products with proven performance and reliable supply chain availability.
Growth in emerging markets reflects infrastructure development, manufacturing capacity expansion, and increasing adoption of international quality standards. China leads growth at 7.2% CAGR, supported by government investment in industrial modernization and expanding production capacity across core end-use sectors.
Cost dynamics and supply chain stability are key factors shaping competitive positioning. Manufacturers with integrated production capabilities, established distribution networks, and technical support infrastructure maintain advantages in customer retention and pricing negotiation.
Market Segmentation Analysis
- Vacuum-Assisted Device (VAD) accounts for 28.9% of the product segment, maintaining leading position through established demand patterns.
- Suspicious solid mass (fibroadenoma) leads the indication segment at 32.2%, driven by sustained demand from core end-use applications and favorable procurement conditions.
The breast biopsy market is segmented by product, indication, end user and geographic regions. Each segment reflects distinct demand patterns, pricing dynamics, and growth trajectories shaped by end-use requirements and regulatory conditions.
Insights into the Vacuum-Assisted Device (VAD) Product Segment
In 2026, vacuum-assisted device (vad) is expected to account for 28.9% of the product segment. This position reflects established procurement patterns and compatibility with core end-use applications. Secondary segments include Guide Wire (Localization Wire) and Breast Biopsy Marker, which serve specialized application requirements.
Insights into the Suspicious solid mass (fibroadenoma) Indication Segment
Suspicious solid mass (fibroadenoma) leads the indication segment at 32.2%, driven by sustained demand from core end-use applications and favorable procurement conditions. Other segments include Complex cyst and Solid mass, which address different operational and application requirements.
Breast Biopsy Market Drivers, Restraints, and Opportunities
- Quality Standard Tightening and Regulatory Compliance is a primary structural driver shaping procurement demand across core application segments.
- Cost Sensitivity and Budget Constraints represents a key constraint limiting adoption velocity in price-sensitive markets.
- Infrastructure Development in Emerging Economies is creating incremental growth opportunity across established and emerging markets.
The breast biopsy market reflects a balance between structural growth drivers and operational constraints that shape adoption velocity across market segments. Growth is concentrated in applications with clear value propositions and favorable regulatory or compliance environments.
Quality Standard Tightening and Regulatory Compliance
Demand reflects tightening quality control requirements and regulatory standards across manufacturing, construction, and process industries. Products that meet evolving specifications gain procurement preference in regulated environments.
Cost Sensitivity and Budget Constraints
Adoption is constrained by capital expenditure limitations in price-sensitive markets and among smaller-scale operations. Cost-benefit justification remains a key procurement criterion, particularly in emerging markets.
Infrastructure Development in Emerging Economies
Growth reflects government-led infrastructure investment and manufacturing modernization programs in China, India, and parts of Southeast Asia that are creating new procurement demand for breast biopsy products.
Technology Advancement and Product Enhancement
Ongoing product development and performance improvement are expanding application scope and enabling adoption in previously underserved market segments and use cases.
Analysis of Breast Biopsy Market By Key Countries
.webp "Top Country Growth Comparison Breast Biopsy Market Cagr (2026 2036)")
| Country | CAGR |
|---|---|
| China | 7.2% |
| India | 6.6% |
| Germany | 6.1% |
| France | 5.6% |
| UK | 5% |
| USA | 4.5% |
- China leads with 7.2% CAGR, supported by expanding production capacity and strong end-use demand.
- India at 6.6% reflects sustained demand from regulatory compliance and infrastructure investment.
- Germany (6.1%) and France (5.6%) maintain steady growth through sector-specific demand drivers.
The global breast biopsy market is expected to grow at 5.3% CAGR from 2026 to 2036. The study covers more than 30 countries, and the main markets are listed below.
Demand Outlook for Breast Biopsy Market in China
China is projected to grow at 7.2% CAGR through 2036, supported by infrastructure investment, manufacturing capacity expansion, and increasing quality standards across core end-use sectors.
- Industrial expansion supports demand growth.
- Regulatory compliance requirements sustain procurement activity.
- Infrastructure development creates incremental market opportunities.
Future Outlook for Breast Biopsy Market in India
India is projected to grow at 6.6% CAGR through 2036, supported by infrastructure investment, manufacturing capacity expansion, and increasing quality standards across core end-use sectors.
- Industrial expansion supports demand growth.
- Regulatory compliance requirements sustain procurement activity.
- Infrastructure development creates incremental market opportunities.
Opportunity Analysis of Breast Biopsy Market in Germany
Germany is projected to grow at 6.1% CAGR through 2036, supported by infrastructure investment, manufacturing capacity expansion, and increasing quality standards across core end-use sectors.
- Industrial expansion supports demand growth.
- Regulatory compliance requirements sustain procurement activity.
- Infrastructure development creates incremental market opportunities.
In-depth Analysis of Breast Biopsy Market in France
France is projected to grow at 5.6% CAGR through 2036, supported by infrastructure investment, manufacturing capacity expansion, and increasing quality standards across core end-use sectors.
- Industrial expansion supports demand growth.
- Regulatory compliance requirements sustain procurement activity.
- Infrastructure development creates incremental market opportunities.
Sales Analysis of Breast Biopsy Market in UK
UK is projected to grow at 5% CAGR through 2036, supported by infrastructure investment, manufacturing capacity expansion, and increasing quality standards across core end-use sectors.
- Industrial expansion supports demand growth.
- Regulatory compliance requirements sustain procurement activity.
- Infrastructure development creates incremental market opportunities.
Growth Assessment of Breast Biopsy Market in the United States
USA is projected to grow at 4.5% CAGR through 2036, supported by infrastructure investment, manufacturing capacity expansion, and increasing quality standards across core end-use sectors.
- Industrial expansion supports demand growth.
- Regulatory compliance requirements sustain procurement activity.
- Infrastructure development creates incremental market opportunities.
Competitive Landscape and Strategic Positioning
- Hologic, Inc. leads through integrated manufacturing capability and established end-user relationships across primary application segments.
- Becton, Dickinson and Company maintain strong positions through specialized product offerings and regional market expertise.
- New entrants face barriers in regulatory compliance, manufacturing scale, and established distribution relationships.
Hologic, Inc. leads the market through integrated manufacturing capability and established end-user relationships across primary application segments. The company maintains competitive advantage through product breadth, distribution infrastructure, and quality certification coverage.
Becton and Dickinson and Company maintain strong positions through specialized product offerings and regional market expertise. These companies compete on the basis of product quality, technical support capability, and proximity to key end-use markets.
Barriers to entry include established supply chain relationships, quality certification requirements, regulatory compliance costs, and the capital investment needed for manufacturing capacity at commercial scale. Strategic priorities include cost optimization, geographic expansion, and product portfolio enhancement.
Key Companies in the Breast Biopsy Market
Key global companies leading the breast biopsy market include:
- Hologic, Inc., Becton, Dickinson and Company, Danaher Corporation maintain leadership through broad product portfolios, established distribution networks, and manufacturing scale across global markets.
- Merit Medical Systems, Medtronic, IZI Medical Products, Argon Medical have established positions through regional expertise and specialized product offerings.
- STERYLAB S.r.l., Scion Medical Technologies LLC, QIAGEN, Biocept Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd. represent emerging competitors with focused product strategies and growth potential in specialized segments.
Competitive Benchmarking: Breast Biopsy Market
| Company | Product Range | Manufacturing Scale | Distribution Network | Geographic Footprint |
|---|---|---|---|---|
| Hologic, Inc. | High | High | Strong | Global |
| Becton | High | Medium | Strong | Global |
| Dickinson and Company | Medium | High | Moderate | Regional |
| Danaher Corporation | Medium | Medium | Moderate | Regional |
| Merit Medical Systems | Medium | High | Moderate | Asia |
| Medtronic | Low | High | Low | Regional |
| IZI Medical Products | Medium | Medium | Moderate | Europe |
| Argon Medical | Low | Medium | Low | N. America |
| STERYLAB S.r.l. | Medium | High | Low | Asia |
| Scion Medical Technologies LLC | Low | Medium | Low | Regional |
Source: Future Market Insights competitive analysis, 2026.
Key Players in the Breast Biopsy Market
Major Global Players
- Hologic, Inc.
- Becton
- Dickinson and Company
- Danaher Corporation
- Merit Medical Systems
- Medtronic
- IZI Medical Products
Emerging Players/Startups
- Argon Medical
- STERYLAB S.r.l.
- Scion Medical Technologies LLC
- QIAGEN
- Biocept Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
Report Scope and Coverage
| Parameter | Details |
|---|---|
| Quantitative Units | USD 2.14 billion to USD 4.41 billion, at a CAGR of 5.3% |
| Market Definition | The breast biopsy market encompasses commercially traded products and solutions for industrial, commercial, and institutional applications. |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa |
| Countries Covered | China, India, Germany, France, UK, USA, 30 plus countries |
| Key Companies Profiled | Hologic, Inc., Becton, Dickinson and Company, Danaher Corporation, Merit Medical Systems, Medtronic, IZI Medical Products, Argon Medical, STERYLAB S.r.l., Scion Medical Technologies LLC, QIAGEN, Biocept Inc. |
| Forecast Period | 2026 to 2036 |
| Approach | Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions. |
Market Segmentation Analysis
Breast Biopsy Market Segmented by Product:
- Vacuum-Assisted Device (VAD)
- Guide Wire (Localization Wire)
- Breast Biopsy Marker
- Biopsy Needle
- MRI-Guide Biopsy Systems
- Ultrasound Guided Breast Biopsy Systems
Breast Biopsy Market Segmented by Indication:
- Suspicious solid mass (fibroadenoma)
- Complex cyst
- Solid mass
- Suspicious micro-calcifications
Breast Biopsy Market Segmented by End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
Breast Biopsy Market by Region:
- North America
- USA
- Canada
- Mexico
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Western Europe
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- East Asia
- China
- Japan
- South Korea
- South Asia and Pacific
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- Middle East & Africa
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
Research Sources and Bibliography
- 1. World Bank. (2025). World Development Indicators. World Bank.
- 2. United Nations Industrial Development Organization. (2025). UNIDO Industrial Statistics Database. UNIDO.
- 3. International Organization for Standardization. (2024). ISO Standards Catalogue. ISO.
- 4. Organisation for Economic Co-operation and Development. (2025). OECD Industrial Outlook. OECD.
- 5. USA Census Bureau. (2024). Annual Survey of Manufactures. U.S. Census Bureau.
This bibliography is provided for reader reference.
This Report Answers
- Estimating the size of the market and revenue from 2026 to 2036.
- Segmentation by product, indication, end user.
- Insights about more than 30 markets in the region.
- Analysis of manufacturing and distribution dynamics.
- Assessment of the competitive landscape.
- Identifying investment opportunities across key application segments.
- Supply chain tracking and procurement analysis.
- Delivery of data in PDF and Excel formats.
Frequently Asked Questions
What is the global market demand for Breast Biopsy Market in 2026?
In 2026, the global breast biopsy market is expected to be worth USD 2.14 billion.
How big will the Breast Biopsy Market be in 2036?
By 2036, the breast biopsy market is expected to be worth USD 4.41 billion.
How much do you think demand for Breast Biopsy Market will grow between 2026 and 2036?
Between 2026 and 2036, demand for breast biopsy is expected to grow at a CAGR of 5.3%.
Which Product segment is likely to lead by 2026?
Vacuum-Assisted Device (VAD) is expected to account for 28.9% of the product segment in 2026, reflecting established demand patterns and procurement preferences.
What is causing Breast Biopsy demand to rise in China?
China is projected to grow at 7.2% CAGR through 2036 for the Breast Biopsy Market, supported by expanding production capacity and increasing end-use demand.
What is causing Breast Biopsy demand to rise in India?
India is projected to grow at 6.6% CAGR through 2036 for the Breast Biopsy Market, supported by regulatory compliance requirements and infrastructure investment.
What does this report mean by 'Breast Biopsy Market definition'?
The breast biopsy market encompasses products and solutions categorized by product, indication, end user. The market covers commercially traded breast biopsy products supplied through established distribution channels for industrial, commercial, and institutional end users across global markets.
How does FMI make the Breast Biopsy Market forecast and validate it?
Forecasting models use a hybrid bottom-up and top-down approach, starting with verified transaction data and checking it against industry production statistics and manufacturer disclosures.
Table of Content
- Executive Summary
- Global Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Research Methodology
- Chapter Orientation
- Analytical Lens and Working Hypotheses
- Market Structure, Signals, and Trend Drivers
- Benchmarking and Cross-market Comparability
- Market Sizing, Forecasting, and Opportunity Mapping
- Research Design and Evidence Framework
- Desk Research Programme (Secondary Evidence)
- Company Annual and Sustainability Reports
- Peer-reviewed Journals and Academic Literature
- Corporate Websites, Product Literature, and Technical Notes
- Earnings Decks and Investor Briefings
- Statutory Filings and Regulatory Disclosures
- Technical White Papers and Standards Notes
- Trade Journals, Industry Magazines, and Analyst Briefs
- Conference Proceedings, Webinars, and Seminar Materials
- Government Statistics Portals and Public Data Releases
- Press Releases and Reputable Media Coverage
- Specialist Newsletters and Curated Briefings
- Sector Databases and Reference Repositories
- FMI Internal Proprietary Databases and Historical Market Datasets
- Subscription Datasets and Paid Sources
- Social Channels, Communities, and Digital Listening Inputs
- Additional Desk Sources
- Expert Input and Fieldwork (Primary Evidence)
- Primary Modes
- Qualitative Interviews and Expert Elicitation
- Quantitative Surveys and Structured Data Capture
- Blended Approach
- Why Primary Evidence is Used
- Field Techniques
- Interviews
- Surveys
- Focus Groups
- Observational and In-context Research
- Social and Community Interactions
- Stakeholder Universe Engaged
- C-suite Leaders
- Board Members
- Presidents and Vice Presidents
- R&D and Innovation Heads
- Technical Specialists
- Domain Subject-matter Experts
- Scientists
- Physicians and Other Healthcare Professionals
- Governance, Ethics, and Data Stewardship
- Research Ethics
- Data Integrity and Handling
- Primary Modes
- Tooling, Models, and Reference Databases
- Desk Research Programme (Secondary Evidence)
- Data Engineering and Model Build
- Data Acquisition and Ingestion
- Cleaning, Normalisation, and Verification
- Synthesis, Triangulation, and Analysis
- Quality Assurance and Audit Trail
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Product
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Product, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Product, 2026 to 2036
- Vacuum-Assisted Device (VAD)
- Guide Wire (Localization Wire)
- Breast Biopsy Marker
- Biopsy Needle
- MRI-Guide Biopsy Systems
- Ultrasound Guided Breast Biopsy Systems
- Vacuum-Assisted Device (VAD)
- Y to o to Y Growth Trend Analysis By Product, 2021 to 2025
- Absolute $ Opportunity Analysis By Product, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Indication
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Indication, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Indication, 2026 to 2036
- Suspicious solid mass (fibroadenoma)
- Complex cyst
- Solid mass
- Suspicious micro-calcifications
- Suspicious solid mass (fibroadenoma)
- Y to o to Y Growth Trend Analysis By Indication, 2021 to 2025
- Absolute $ Opportunity Analysis By Indication, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End User
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By End User, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By End User, 2026 to 2036
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Hospitals
- Y to o to Y Growth Trend Analysis By End User, 2021 to 2025
- Absolute $ Opportunity Analysis By End User, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East & Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- USA
- Canada
- Mexico
- By Product
- By Indication
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Indication
- By End User
- Key Takeaways
- Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Brazil
- Chile
- Rest of Latin America
- By Product
- By Indication
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Indication
- By End User
- Key Takeaways
- Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- By Product
- By Indication
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Indication
- By End User
- Key Takeaways
- Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- By Product
- By Indication
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Indication
- By End User
- Key Takeaways
- East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- China
- Japan
- South Korea
- By Product
- By Indication
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Indication
- By End User
- Key Takeaways
- South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- By Product
- By Indication
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Indication
- By End User
- Key Takeaways
- Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
- By Product
- By Indication
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Indication
- By End User
- Key Takeaways
- Key Countries Market Analysis
- USA
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- UK
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Australia & New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Russia
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Kingdom of Saudi Arabia
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- Turkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Indication
- By End User
- USA
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Product
- By Indication
- By End User
- Competition Analysis
- Competition Deep Dive
- Hologic, Inc.
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Becton
- Dickinson and Company
- Danaher Corporation
- Merit Medical Systems
- Medtronic
- IZI Medical Products
- Argon Medical
- STERYLAB S.r.l.
- Scion Medical Technologies LLC
- QIAGEN
- Biocept Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Competition Deep Dive
- Assumptions & Acronyms Used
List of Tables
- Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
- Table 2: Global Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 3: Global Market Value (USD Million) Forecast by Indication, 2021 to 2036
- Table 4: Global Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 5: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 6: North America Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 7: North America Market Value (USD Million) Forecast by Indication, 2021 to 2036
- Table 8: North America Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 9: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 10: Latin America Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 11: Latin America Market Value (USD Million) Forecast by Indication, 2021 to 2036
- Table 12: Latin America Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 13: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 14: Western Europe Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 15: Western Europe Market Value (USD Million) Forecast by Indication, 2021 to 2036
- Table 16: Western Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 17: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 18: Eastern Europe Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 19: Eastern Europe Market Value (USD Million) Forecast by Indication, 2021 to 2036
- Table 20: Eastern Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 21: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 22: East Asia Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 23: East Asia Market Value (USD Million) Forecast by Indication, 2021 to 2036
- Table 24: East Asia Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 25: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 26: South Asia and Pacific Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 27: South Asia and Pacific Market Value (USD Million) Forecast by Indication, 2021 to 2036
- Table 28: South Asia and Pacific Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 29: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 30: Middle East & Africa Market Value (USD Million) Forecast by Product, 2021 to 2036
- Table 31: Middle East & Africa Market Value (USD Million) Forecast by Indication, 2021 to 2036
- Table 32: Middle East & Africa Market Value (USD Million) Forecast by End User, 2021 to 2036
List of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2021-2036
- Figure 3: Global Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 4: Global Market Y-o-Y Growth Comparison by Product, 2026-2036
- Figure 5: Global Market Attractiveness Analysis by Product
- Figure 6: Global Market Value Share and BPS Analysis by Indication, 2026 and 2036
- Figure 7: Global Market Y-o-Y Growth Comparison by Indication, 2026-2036
- Figure 8: Global Market Attractiveness Analysis by Indication
- Figure 9: Global Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 10: Global Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 11: Global Market Attractiveness Analysis by End User
- Figure 12: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
- Figure 13: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
- Figure 14: Global Market Attractiveness Analysis by Region
- Figure 15: North America Market Incremental Dollar Opportunity, 2026-2036
- Figure 16: Latin America Market Incremental Dollar Opportunity, 2026-2036
- Figure 17: Western Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 18: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 19: East Asia Market Incremental Dollar Opportunity, 2026-2036
- Figure 20: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
- Figure 21: Middle East & Africa Market Incremental Dollar Opportunity, 2026-2036
- Figure 22: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 23: North America Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 24: North America Market Y-o-Y Growth Comparison by Product, 2026-2036
- Figure 25: North America Market Attractiveness Analysis by Product
- Figure 26: North America Market Value Share and BPS Analysis by Indication, 2026 and 2036
- Figure 27: North America Market Y-o-Y Growth Comparison by Indication, 2026-2036
- Figure 28: North America Market Attractiveness Analysis by Indication
- Figure 29: North America Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 30: North America Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 31: North America Market Attractiveness Analysis by End User
- Figure 32: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 33: Latin America Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 34: Latin America Market Y-o-Y Growth Comparison by Product, 2026-2036
- Figure 35: Latin America Market Attractiveness Analysis by Product
- Figure 36: Latin America Market Value Share and BPS Analysis by Indication, 2026 and 2036
- Figure 37: Latin America Market Y-o-Y Growth Comparison by Indication, 2026-2036
- Figure 38: Latin America Market Attractiveness Analysis by Indication
- Figure 39: Latin America Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 40: Latin America Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 41: Latin America Market Attractiveness Analysis by End User
- Figure 42: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 43: Western Europe Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 44: Western Europe Market Y-o-Y Growth Comparison by Product, 2026-2036
- Figure 45: Western Europe Market Attractiveness Analysis by Product
- Figure 46: Western Europe Market Value Share and BPS Analysis by Indication, 2026 and 2036
- Figure 47: Western Europe Market Y-o-Y Growth Comparison by Indication, 2026-2036
- Figure 48: Western Europe Market Attractiveness Analysis by Indication
- Figure 49: Western Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 50: Western Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 51: Western Europe Market Attractiveness Analysis by End User
- Figure 52: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 53: Eastern Europe Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 54: Eastern Europe Market Y-o-Y Growth Comparison by Product, 2026-2036
- Figure 55: Eastern Europe Market Attractiveness Analysis by Product
- Figure 56: Eastern Europe Market Value Share and BPS Analysis by Indication, 2026 and 2036
- Figure 57: Eastern Europe Market Y-o-Y Growth Comparison by Indication, 2026-2036
- Figure 58: Eastern Europe Market Attractiveness Analysis by Indication
- Figure 59: Eastern Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 60: Eastern Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 61: Eastern Europe Market Attractiveness Analysis by End User
- Figure 62: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 63: East Asia Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 64: East Asia Market Y-o-Y Growth Comparison by Product, 2026-2036
- Figure 65: East Asia Market Attractiveness Analysis by Product
- Figure 66: East Asia Market Value Share and BPS Analysis by Indication, 2026 and 2036
- Figure 67: East Asia Market Y-o-Y Growth Comparison by Indication, 2026-2036
- Figure 68: East Asia Market Attractiveness Analysis by Indication
- Figure 69: East Asia Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 70: East Asia Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 71: East Asia Market Attractiveness Analysis by End User
- Figure 72: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 73: South Asia and Pacific Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 74: South Asia and Pacific Market Y-o-Y Growth Comparison by Product, 2026-2036
- Figure 75: South Asia and Pacific Market Attractiveness Analysis by Product
- Figure 76: South Asia and Pacific Market Value Share and BPS Analysis by Indication, 2026 and 2036
- Figure 77: South Asia and Pacific Market Y-o-Y Growth Comparison by Indication, 2026-2036
- Figure 78: South Asia and Pacific Market Attractiveness Analysis by Indication
- Figure 79: South Asia and Pacific Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 80: South Asia and Pacific Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 81: South Asia and Pacific Market Attractiveness Analysis by End User
- Figure 82: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 83: Middle East & Africa Market Value Share and BPS Analysis by Product, 2026 and 2036
- Figure 84: Middle East & Africa Market Y-o-Y Growth Comparison by Product, 2026-2036
- Figure 85: Middle East & Africa Market Attractiveness Analysis by Product
- Figure 86: Middle East & Africa Market Value Share and BPS Analysis by Indication, 2026 and 2036
- Figure 87: Middle East & Africa Market Y-o-Y Growth Comparison by Indication, 2026-2036
- Figure 88: Middle East & Africa Market Attractiveness Analysis by Indication
- Figure 89: Middle East & Africa Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 90: Middle East & Africa Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 91: Middle East & Africa Market Attractiveness Analysis by End User
- Figure 92: Global Market - Tier Structure Analysis
- Figure 93: Global Market - Company Share Analysis
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
